Kiniksa Pharmaceuticals International (KNSA) EPS (Diluted) (2019 - 2026)
Kiniksa Pharmaceuticals International (KNSA) reported EPS (Diluted) of $0.30 for Q2 2026, up 33.3% from $0.23 a year earlier and up 11.2% from the prior quarter.
Powered by 
Analysis
Kiniksa Pharmaceuticals International (KNSA) EPS (Diluted) (2019 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Kiniksa Pharmaceuticals International's EPS (Diluted) came in at $0.97; for FY2025, it was $0.75.
- By year, EPS (Diluted) came in at -$0.60 in FY2024, $0.20 in FY2023 (-92.5%), $2.60 in FY2022 and -$2.30 in FY2021.
- The Q2 2026 figure ranks as the highest quarterly EPS (Diluted) since Q4 2023.
- Per Business Quant data, the three quarters before Q2 2026 came in at $0.27 (Q1 2026), $0.18 (Q4 2025) and $0.23 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 7.94 |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 2.27 |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 2.04 |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | -0.54 |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 1.67 |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 1.85 |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 4.37 |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -8.44 |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | -0.04 |
| 10 | Kiniksa Pharmaceuticals International | 11.73 Bn | 10.47 Bn | 220.03 Mn | 0.30 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.30 |
| Mar 31, 2026 | 0.27 |
| Dec 31, 2025 | 0.18 |
| Sep 30, 2025 | 0.23 |
| Jun 30, 2025 | 0.23 |
| Mar 31, 2025 | 0.11 |
| Dec 31, 2024 | -0.12 |
| Sep 30, 2024 | -0.18 |
| Jun 30, 2024 | -0.06 |
| Mar 31, 2024 | -0.25 |
| Dec 31, 2023 | 0.35 |
| Sep 30, 2023 | -0.20 |
| Jun 30, 2023 | 0.21 |
| Mar 31, 2023 | -0.18 |
| Dec 31, 2022 | 0.06 |
| Sep 30, 2022 | 3.18 |
| Jun 30, 2022 | -0.29 |
| Mar 31, 2022 | -0.36 |
| Dec 31, 2021 | -0.53 |
| Sep 30, 2021 | -0.44 |
API Access
Kiniksa Pharmaceuticals International EPS (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-diluted&ticker=KNSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-diluted", "ticker": "KNSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=eps-diluted&ticker=KNSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();